47045-STP-T-UNDP-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Reduction of TB prevalence by 6 % by 2017 - Sao Tome and Principe (01-Jul-2015-31-Dec-2017)</narrative> Sao Tome and Principe, Tuberculosis, United Nations Development Programme Goal: Ending the Tuberculosis epidemic in Sao Tome and Principe by 2035. Objectives: Increase TB case notification rates from 71 cases / 100,000 inhabitants in 2012 to 80 cases / 100,000 in 2017 through increased screening among key populations; Increase TB treatment success rates to more than 85%, by putting the emphasis on rigorous directly observed treatment (DOTs); Provide care and support to more than 95% of TB/HIV co-infected patients through HIV testing of more than 95% of TB patients; TB screening for all PLHIV; and treatment provision (Cotrimoxazole, ART) to TB/HIV;; Provide routine screening of resistance through Xpert test in all TB cases and the treatment of MDR-TB; To improve the managerial capacity of the National Tuberculosis Programme (PNLT). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Sao Tome and Principe Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 881594.00 Global Fund commitment to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 881594.00 Global Fund disbursement to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 439712.00 Global Fund commitment to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 40000.00 Global Fund disbursement to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 162541.12 Global Fund disbursement to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 227170.88 Global Fund disbursement to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -10000.00 Global Fund commitment to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 106396.00 Global Fund commitment to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 106396.00 Global Fund disbursement to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 25000.00 Global Fund commitment to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 40565.00 Global Fund commitment to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 40565.00 Global Fund disbursement to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -25000.00 Global Fund commitment to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -11499.78 Global Fund commitment to STP-T-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 11499.78 Funds returned to the Global Fund from STP-T-UNDPP01. United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National. Aggregation: Cumulative annually. <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative> Module: TB care and prevention. <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative> Geographic coverage: National. Aggregation: Cumulative annually. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 8; Denominator: 8. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 148; Denominator: 195. Numerator: 139; Denominator: 178. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 37; Denominator: 37. Numerator: 21; Denominator: 21.